Work

Figure S3 from Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

Year: 2023
Type: other
Abstract: c-Myc knockdown augments oeimertinib-induced apoptosis in HCC827/AR cells.
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361879343
Cites:
Cited by:
Related to: 10